Feb 22, 2017
Before he gave us his experience of modern medical trials Prof. Peter Sandercock sat down with Mark Pentler to talk about the challenges of keeping up with current research, who is at fault for people's misunderstanding of trial results, and what can be done about it. We also delve into Peter's journey into skepticism.
Professor Peter Sandercock (Emeritus Professor of Neurology, University of Edinburgh) set up and ran the first International Stroke Trial (IST-1), the first ‘mega-trial’ in acute ischaemic stroke. More recently, he is the Co-Chief Investigator of IST-3, the largest-ever trial of ‘clot-busting’ thrombolytic therapy for acute ischaemic stroke with over 3,000 patients recruited. In this talk he will expose the challenges and explore the successes of clinical trials in the modern era and how they can bring us not only new treatments and new answers, but also new questions.